Skip to main content

Table 4 Occurrence of antimicrobial resistance among Escherichia coli isolated from diseased pigs in different European countries.

From: Occurrence of antimicrobial resistance among bacterial pathogens and indicator bacteria in pigs in different European countries from year 2002 – 2004: the ARBAO-II study

Antimicrobial agent

Year

Country and prevalence of resistance

  

B

DK

E

FIN

F

LV

NL

N

P

ES

S

CH

Ampicillin

2002

55.7

45.0

43.0

13.0

49.9

-

92.9

13.0

-

77.0

19.0

-

 

2003

69.2

42.9

51.0

15.4

51.5

65.0

93.0

-

-

70.1

14.0

21.0

 

2004

72.3

45.8

47.0

16.0

53.2

-

-

7.0

-

72.2

22.0

4.2

Amoxicillin – Clavulanic acid

2002

11.5

-

-

-

2.7

-

0.1

-

58.0

1.0

-

-

 

2003

4.4

3.9

-

-

9.2

24.0

1.0

-

31.0

2.6

-

0.0

 

2004

0.7

0.6

-

-

2.0

-

-

-

36.0

1.8

-

0.0

Apramycin

2002

6.6

17.0

12.0

-

3.0

-

-

3.0

-

23.0

-

-

 

2003

13.2

9.1

16.0

-

3.7

-

-

-

-

20.8

-

-

 

2004

13.1

13.6

8.0

-

3.3

-

-

-

-

13.0

-

-

Ceftiofur

2002

1.6

0.0

-

-

0.1

-

-

0.0

-

1.0

0.0

-

 

2003

2.2

0.0

-

0.0

0.0

-

-

-

-

-

0.0

0.0

 

2004

0.7

0.0

-

0.0

0.6

-

-

0.0

-

3.6

<1.0

-

Chloramphenicol

2002

49.2

31.0

-

-

-

-

-

0.0

42.0

45.0

-

-

 

2003

34.1

25.0

-

3.1

-

-

-

-

49.0

35.1

-

18.7

 

2004

38.7

41.8

-

7.0

-

-

-

4.0

45.0

40.8

-

38.3

Ciprofloxacin

2002

3.3

0.0

8.0

4.0

4.7

-

-

0.0

76.0a

15.0

7.0

-

 

2003

1.1

0.0

2.0

1.5

6.2

22.0

-

-

38.0a

14.9

0.0

1.3

 

2004

2.9

0.0

2.0

0.0

5.5

-

-

0.0

30.0a

14.2

6.0

0.0

Florfenicol

2002

1.6

0.0

-

-

2.0

-

-

0.0

-

4.0

0.6

-

 

2003

2.2

1.3

-

1.5

1.2

-

-

-

-

7.1

0.0

-

 

2004

4.4

0.0

-

0.0

0.9

-

-

0.0

-

7.1

-

-

Gentamicin

2002

4.9

14.0

-

-

5.6

-

0.0

3.0

58.0

25.0

1.0

-

 

2003

1.1

6.5

-

0.0

6.1

15.0

-

-

33.0

19.5

2.0

15.8

 

2004

3.6

12.0

-

0.0

5.5

-

-

0.0

45.0

19.5

0.0

12.7

Nalidixic acid

2002

19.7

19.0

-

-

17.1

-

0.0

0.0

85.0b

45.0

-

-

 

2003

18.7

25.3

-

21.5

-

35.0

<1.0

-

-

42.2

-

-

 

2004

34.3

32.0

-

13.0

-

-

-

2.0

-

33.7

-

-

Neomycin

2002

14.8

36.0

11.0

-

10.6

-

0.0

0.0

-

26.0

4.0

-

 

2003

2.2

31.2

19.0

3.1

11.8

48.0

0.0

-

-

24.7

6.0

12.2

 

2004

1.5

35.0

11.0

7.0

10.9

-

-

2.0

-

20.1

4.0

-

Streptomycin

2002

-

77.0

-

45.0

-

-

-

54.0

79.0

73.0

33.0

-

 

2003

-

66.3

-

47.7

-

92.0

-

-

60.0

73.4

32.0

-

 

2004

-

77.4

-

54.0

-

-

-

47.0

64.0

74.0

28.0

-

Sulphonamide

2002

-

77.0

-

-

-

-

-

23.0

-

82.0

-

-

 

2003

-

72.7

-

33.8

-

92.0

-

-

-

74.7

-

-

 

2004

-

82.0

-

51.0

-

-

-

7.0

-

76.3

-

-

Tetracycline

2002

75.4

75.0

85.0

44.0

86.2

-

-

41.0

94.0

86.0

28.0

-

 

2003

80.2

72.7

83.0

46.2

84.7

86.0

-

-

91.0

86.4

23.0

57.8

 

2004

77.4

91.0

82.0

51.0

82.6

-

-

24.0

98.0

87.0

27.0

57.4

Trimethoprim

2002

-

-

-

-

-

-

-

15.0

-

63.0

-

-

 

2003

-

-

-

29.2

-

-

-

-

-

72.1

-

-

 

2004

-

-

-

44.0

-

-

-

7.0

-

66.9

27.0

-

Trimethoprim – Sulphonamide

2002

67.2

38.0

52.0

38.0

65.1

-

73.7

-

-

-

21.0

-

 

2003

70.3

36.4

-

-

66.9

79.0

21.5

-

-

-

-

21.5

 

2004

70.8

48.6

55.0

-

66.4

-

-

-

-

-

-

-

  1. -: No data available, a: enrofloxacin used, b: flumequine used. B – Belgium, DK – Denmark, E – England including Wales; F – France; FIN – Finland; LV – Latvia; NL – The Netherlands; N – Norway; P – Portugal; ES – Spain; S – Sweden; CH – Switzerland.